11-04-2025 17:48 via drugs.com

Breast Surgery Can Be Omitted After Neoadjuvant Systemic Therapy in Select Patients

FRIDAY, April 11, 2025-- Omission of breast surgery after neoadjuvant systemic therapy (NST) in select patients with invasive breast cancer may be feasible, according to a study published online March 28 in the Journal of the American Medical...
Read more »

Pharmaceutical news



Midafternoon Dosing Improves Lung Function in Atopic Asthma
Acute Care for Cannabis Use Increases Risk for Subsequent New Dementia Diagnosis
Recent Years Saw Increase in U.S. Pregnancy-Related Deaths
Guidelines Developed to Improve Newborn Screening for Cystic Fibrosis
Age-Adjusted Ischemic Stroke Mortality Increased Since 2009
MicroRNA-Based Germline Signature Predicts RT-Induced Genitourinary Toxicity in Prostate Cancer
Observation of Predictable Visual Stimuli a Potential Early Indicator for Autism
Trump Administration Plans Deep Cuts to Federal Health Budget
Gastrointestinal Disease Tied to High Physical, Financial Burden
Top NIH Nutrition Researcher Quits, Citing Censorship Under Kennedy
HHS Fires Team That Sets Federal Poverty Guidelines
First Weight-Loss Pill From Lilly Shows Promising Results
First Weight-Loss Pill From Lilly, Orforglipron, Shows Promising Results
Allergy Expert Gives Tips On Seasonal Allergies
Desktop versie